Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ede, Ronald"'
Autor:
Schmidt, C., Ahmad, T., Tulassay, Z., Baumgart, D. C., Bokemeyer, B., Howaldt, S., Stallmach, A., Büning, C., Baumgart, Daniel C., Bokemeyer, Bernd, Büning, Carsten, Helwig, Ulf, Howaldt, Stefanie, Hüppe, Dietrich, Krummenerl, Annette, Krummenerl, Thomas, Kühbacher, Tanja, Landry, Wilfried, Lügering, Andreas, Maaser, Christian, Mroß, Michael, Seidler, Ursula, Stallmach, Andreas, Stein, Jürgen, Teich, Niels, Horvath, Gabor, Kristóf, Tünde, László, András, Molnár, Tamás, Salamon, Ágnes, Tulassay, Zsolt, Vincze, Áron, Krayenbuehl, Pierre, Ahmad, Tariq, Beales, Ian, Brookes, Matthew, Campbell, Simon, Cummings, Fraser, Ede, Ronald, Elphick, David, Ireland, Alan, Kejariwal, Deepak, Li, Andy, Mansfield, John
Publikováno v:
Alimentary Pharmacology and Therapeutics, 44(3), 259-270. Wiley
Alimentary Pharmacology & Therapeutics
Schmidt, C, Ahmad, T, Tulassay, Z, Baumgart, D C, Bokemeyer, B, Howaldt, S, Stallmach, A & de Cock Buning, J T 2016, ' Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study ', Alimentary Pharmacology and Therapeutics, vol. 44, no. 3, pp. 259-270 . https://doi.org/10.1111/apt.13665
Alimentary Pharmacology & Therapeutics
Schmidt, C, Ahmad, T, Tulassay, Z, Baumgart, D C, Bokemeyer, B, Howaldt, S, Stallmach, A & de Cock Buning, J T 2016, ' Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study ', Alimentary Pharmacology and Therapeutics, vol. 44, no. 3, pp. 259-270 . https://doi.org/10.1111/apt.13665
Summary Background Ferric maltol was effective and well‐tolerated in iron deficiency anaemia patients with inflammatory bowel disease during a 12‐week placebo‐controlled trial. Aim To perform a Phase 3 extension study evaluating long‐term eff
Autor:
EDE, RONALD
Publikováno v:
Nature; 6/12/1943, Vol. 151 Issue 3841, p673-673, 1p